Ozurdex — Net revenues
Products & Services · Net revenuesAbbVie Ozurdex — Net revenues increased by 9.4% to $128.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $120.00M to $128.00M. Over 4 years (FY 2021 to FY 2025), Ozurdex — Net revenues shows an upward trend with a 4.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market penetration or higher patient demand for the product, while a decrease may signal increased competition, patent expirations, or shifts in clinical treatment guidelines.
Detailed definition
This metric represents the total net sales generated from the Ozurdex product line, an intravitreal implant used for the...
Peer comparison
Comparable to specialized product revenue lines in other pharmaceutical companies, particularly those focused on ophthalmology or specialty drug franchises.
abbv_segment_ozurdex_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.50M | $104.50M | $104.50M | $107.00M | $110.00M | $106.00M | $105.00M | $115.00M | $119.00M | $120.00M | $118.00M | $131.00M | $124.00M | $119.00M | $120.00M | $123.00M | $125.00M | $117.00M | $128.00M |
| QoQ Change | — | +0.0% | +0.0% | +2.4% | +2.8% | -3.6% | -0.9% | +9.5% | +3.5% | +0.8% | -1.7% | +11.0% | -5.3% | -4.0% | +0.8% | +2.5% | +1.6% | -6.4% | +9.4% |
| YoY Change | — | — | — | — | +5.3% | +1.4% | +0.5% | +7.5% | +8.2% | +13.2% | +12.4% | +13.9% | +4.2% | -0.8% | +1.7% | -6.1% | +0.8% | -1.7% | +6.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's ozurdex — net revenues?
- AbbVie (ABBV) reported ozurdex — net revenues of $128.00M in Q4 2025.
- How has AbbVie's ozurdex — net revenues changed year-over-year?
- AbbVie's ozurdex — net revenues increased by 6.7% year-over-year, from $120.00M to $128.00M.
- What is the long-term trend for AbbVie's ozurdex — net revenues?
- Over 4 years (2021 to 2025), AbbVie's ozurdex — net revenues has grown at a 4.2% compound annual growth rate (CAGR), from $418.00M to $493.00M.
- What does ozurdex — net revenues mean?
- The total net revenue generated from sales of the Ozurdex ocular implant product.